Exp Mol Med.
2011 Sep;43(9):501-509. 10.3858/emm.2011.43.9.057.
Down-regulation of survivin suppresses uro-plasminogen activator through transcription factor JunB
- Affiliations
-
- 1Department of Hematology-Oncology, College of Medicine, Yeungnam University, Daegu 705-717, Korea.
- 2Department of Gastro-Enterology, College of Medicine, Yeungnam University, Daegu 705-717, Korea.
- 3Department of Surgery, College of Medicine, Yeungnam University, Daegu 705-717, Korea.
- 4Department of Pathology, College of Medicine, Yeungnam University, Daegu 705-717, Korea.
- 5Department of Biochemistry and Molecular Biology, College of Medicine, Yeungnam University, Daegu 705-717, Korea. kimjr@med.yu.ac.kr
- 6Aging-associated Vascular Disease Research Center, College of Medicine, Yeungnam University, Daegu 705-717, Korea.
- KMID: 1022126
- DOI: http://doi.org/10.3858/emm.2011.43.9.057
Abstract
- Survivin, a member of the inhibitors of apoptosis protein family, is expressed during development and in various human cancers. However, the clinical relevance of survivin in cancer is still a matter of debate. Genes induced by hepatocyte growth factor (HGF) were screened using cDNA microarray technology in the stomach cancer cell lines, NUGC3 and MKN28. The levels of JunB, survivin, and uro-plasminogen activator (uPA) were up-regulated in cells treated with HGF in a dose-dependent manner. HGF-induced up regulation of JunB, survivin, and uPA was inhibited by pre-treatment with a MEK inhibitor (PD 98059). HGF-induced up-regulation of uPA was repressed by survivin knockdown. HGF enhanced the binding activity of JunB to the survivin promoter in control cells, but not in the JunB-shRNA cells. Transfection with survivin-shRNA resulted in a decrement of cell proliferation, as determined with MTT assays. In an in vitro invasion assay, significantly fewer cells transfected with survivin shRNA than control cells were able to invade across a Matrigel membrane barrier. In conclusion, survivin appeared to play an important role in the up-regulation of uPA induced by HGF via JunB and might contribute to HGF-mediated tumor invasion and metastasis, which may serve as a promising target for gastric cancer therapy.
Keyword
MeSH Terms
-
Apoptosis
Cell Hypoxia
Cell Line, Tumor
*Cytoprotection
Glutathione Peroxidase/metabolism
Herbicides/*toxicity
Humans
L-Lactate Dehydrogenase/metabolism
Lung/*cytology/*drug effects/metabolism
Malondialdehyde/metabolism
Oxidative Stress
Paraquat/*toxicity
Reactive Oxygen Species/*metabolism
Superoxide Dismutase/metabolism
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Effect of immune-mediated vascular injury on the coagulation- regulatory mechanism of the human endothelial cells; changes of tissue-type plasminogen activator, plasminogen activator inhibitor- 1 and von Willebrand factor
- Urokinase-type plasminogen activator receptor in IgA nephropathy
- The Expression of c-Jun and JunB in Various Skin Tumors
- Expression of type I plasminogen activator inhibitor in renal tissue in murine lupus
- Effects of the dosing regimen of tissue-type plasminogen activator on blood coagulation system in experimental pulmonary embolism
